1830OLiquid biopsy as tool to monitor and predict clinical...

Annals of Oncology 2018 / 10 Vol. 29; Iss. suppl_8

1830OLiquid biopsy as tool to monitor and predict clinical benefit from chemotherapy (CT) and immunotherapy (IT) in advanced non-small cell lung cancer (aNSCLC): A prospective study

Bonanno, L, Zulato, E, Attili, I, Pavan, A, Del Bianco, P, Nardo, G, Verza, M, Pasqualini, L, Pasello, G, Zago, G, Frega, S, Fassan, M, Calabrese, F, Amadori, A, Guarneri, V, Conte, P F, Indraccolo, S
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
29
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy303
Date:
October, 2018
File:
PDF, 93 KB
english, 2018
Conversion to is in progress
Conversion to is failed